For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal ...

The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...

Explore the latest advancements in treating ulcerative colitis using machine learning to discover new antimicrobial peptides.

Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics, family communication, and side effects.

Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients in the PRA023 group achieved clinical remission at 12 weeks vs. placebo (26.5% ...

A machine learning-based computational approach to accelerate therapeutic discoveryUlcerative colitis (UC) is a chronic inflammatory bowel disease ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

(MENAFN- EIN Presswire) EINPresswire/ -- Ulcerative Colitis Market to Surpass $26 billion in 2030. Within the broader Healthcare Services industry, which is expected to be $10,759 billion by 2030, the ...

Nearly 70% of adolescents and young adults stop taking oral 5-aminosalicylic acid (5-ASA) maintenance therapy within 12 months of ulcerative colitis (UC) diagnosis, new research from the United ...